Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial
Not Applicable
- Conditions
- Lung Cancer
- Registration Number
- NCT04954625
- Lead Sponsor
- Rush University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion Criteria:<br><br> - Patients who underwent elective wedge resection, segmentectomy, lobectomy, or<br> bilobectomy for suspected non-small cell lung cancer<br><br> - Patients that have reviewed and signed the Informed Consent Form, had an opportunity<br> to ask questions, and consent to have their de-identified data included in the study<br><br> - Patients who have an air leak on the morning of postoperative Day 3<br><br> - Age =18 years old<br><br>Exclusion Criteria:<br><br> - Patients who undergo pneumonectomy, sleeve lobectomy, chest wall or diaphragm<br> resection, or bilateral procedures.<br><br> - Age < 18 years old<br><br> - Women who are pregnant
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prolonged Air Leak >5 days;Hospital Length of Stay;Readmission within 30 days;In hospital mortality;30-day Mortality
- Secondary Outcome Measures
Name Time Method